Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Hiromasa, Yoshioka"'
Publikováno v:
Anticancer Research. 42:4173-4178
Standard treatment options for primary central nervous system lymphoma (PCNSL) include high-dose methotrexate (HD-MTX)-based drug therapy and whole-brain radiation therapy. However, there are many cases in which these standard treatment options are n
Publikováno v:
Anticancer research. 40(8)
Background/aim Recent advances in systemic chemotherapy, including molecularly targeted therapy, have dramatically improved survival for patients with advanced non-small cell lung cancer. We retrospectively analyzed the clinical outcomes of surgical
Autor:
Takeshi Okuda, Shuichi Izumoto, Kimihiro Yamashita, Mitsugu Fujita, Susumu Nakata, Takayuki Tasaki, Hiromasa Yoshioka, Amami Kato
Publikováno v:
Anticancer research. 37(7)
Background Glioblastoma multiforme (GBM) is a malignant brain tumor with an extremely poor prognosis. GBM tissues frequently express mesenchymal-epithelial transition factor (MET), which induces cell division, growth and migration. In addition, angio
Autor:
Takayuki, Tasaki, Mitsugu, Fujita, Takeshi, Okuda, Azusa, Yoneshige, Susumu, Nakata, Kimihiro, Yamashita, Hiromasa, Yoshioka, Shuichi, Izumoto, Amami, Kato
Publikováno v:
Anticancer research. 36(7)
Glioblastoma multiforme (GBM) is the most frequent and the most malignant tumor among adult brain tumors. Previous reports led us to hypothesize that the proto-oncogene mesenchymal-epithelial transition (MET) expressed in glioma stem cell-like cells
Publikováno v:
Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia. 19(12)
We have developed a technique of fluorescence-guided surgery using high-dose fluorescein sodium (20mg/kg) with excitation and barrier filters for glioblastoma multiforme surgery. This technique was used in 10 patients, with surgery proceeding as expe